Marielle Buisson Selected Research

Marielle Buisson Research Topics

13	Stroke (Strokes) 05/2022 - 01/2017
10	Ischemic Stroke 05/2022 - 01/2020
5	COVID-19 04/2022 - 07/2021
4	Infarction (Infarctions) 01/2021 - 01/2017
3	Critical Illness (Critically Ill) 04/2022 - 03/2022
2	ST Elevation Myocardial Infarction 05/2022 - 01/2022
2	Sepsis (Septicemia) 03/2022 - 05/2019
2	Hypertension (High Blood Pressure) 03/2022 - 01/2021
2	Infections 05/2019 - 09/2002
2	Viremia 04/2005 - 05/2002
1	Heart Failure 05/2022
1	Myocardial Infarction 05/2022
1	Lymphopenia (Lymphocytopenia) 04/2022
1	Thrombosis (Thrombus) 03/2022
1	Neurocognitive Disorders (Clerambault Syndrome) 09/2021
1	Myalgia 09/2021
1	Embolic Stroke 01/2021
1	Septic Shock (Toxic Shock Syndrome) 05/2019
1	Heart Arrest (Cardiac Arrest) 05/2019
1	Ischemia 01/2017
1	Type 2 Diabetes Mellitus (MODY) 03/2015
1	Lipodystrophy 03/2006
1	Atherosclerosis 03/2006
1	Drug-Related Side Effects and Adverse Reactions 07/2004
1	Hepatitis 11/2003
1	Coinfection 11/2003
1	Pneumonia (Pneumonitis) 09/2002
1	Pneumococcal Infections 09/2002
1	Pneumococcal Pneumonia 09/2002
1	Hepatitis C 05/2002

3	Biological ProductsIBA 03/2022 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2021
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 01/2020
2	Interleukin-7 (Interleukin 7)IBA 04/2022 - 03/2022
1	omega-Chloroacetophenone (Mace)IBA 05/2022
1	HLA-DR Antigens (HLA-DR)IBA 04/2022
1	Fibrinogen (Factor I)FDA Link 09/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2015
1	oxidized low density lipoproteinIBA 03/2006
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 03/2006
1	Stavudine (Zerit)FDA LinkGeneric 03/2006
1	RNA (Ribonucleic Acid)IBA 04/2005
1	Nevirapine (Viramune)FDA Link 04/2005
1	Reverse Transcriptase InhibitorsIBA 07/2004
1	Pharmaceutical PreparationsIBA 07/2004
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2004
1	Alkaline PhosphataseIBA 11/2003
1	EnzymesIBA 11/2003
1	QuinolonesIBA 09/2002
1	Penicillins (Penicillin)FDA Link 09/2002
1	FluoroquinolonesIBA 09/2002
1	Levofloxacin (Levaquin)FDA Link 09/2002
1	Ciprofloxacin (Cipro)FDA LinkGeneric 09/2002
1	DNA (Deoxyribonucleic Acid)IBA 05/2002

12	Thrombectomy 05/2022 - 01/2020
8	Therapeutics 05/2022 - 05/2002
2	Percutaneous Coronary Intervention 05/2022 - 01/2022
1	Immunomodulation 03/2022
1	Contraindications 05/2019
1	Highly Active Antiretroviral Therapy (HAART) 11/2003